Virginia Drug Discovery Consortium

The Virginia Drug Discovery Consortium (VaDDC) has a threefold mission:

To promote the growth and advancement of drug discovery and development programs at universities and research institutes within Virginia, particularly through inter-institutional collaboration.

To help the pharmaceutical industry bring life-saving and quality of life solutions to patients through innovative collaborations with Virginia’s best and brightest researchers.

To promote and enhance the attractiveness of Virginia as an environment for pharmaceutical and biotech companies.

Work with us

EVENTS

VirginiaDrugDiscoveryRx: Emerging Targets, Technologies, and Therapeutics for Cancer and Neuroscience

The VaDDC Executive Committee is pleased to announce the VirginiaDrugDiscoveryRx: Emerging Targets, Technologies, and Therapeutics for Cancer and Neuroscience meeting will be held at the

Hotel Roanoke – May 21, 22, 2019

See Details for the Meeting on our Events Page.

Special Note – Keynote Speaker: Susan Band Horwitz, Ph.D., has been named one of seven winners of the 2019 Canada Gairdner Award, the country’s highest scientific prize.

REGISTER
Symposium Agenda

⇒ At least 4 Poster prizes will be presented at the Symposium. See the event registration page for details.

Thank you to our sponsors whose participation in the

VirginiaDrugDiscoveryRx: Emerging Targets,Technologies, and Therapeutics Symposium

to be held at the

Hotel Roanoke, May 21-22, 2019

is key to the meeting’s success.

NEWS

Webster Santos – VT and Kevin Lynch-UVA received a $2.8 NIAID grant to Develop a Drug to Treat Multiple Sclerosis

Santos received this research grant in collaboration with Kevin Lynch, a professor of pharmacology at the University of Virginia. Lynch will oversee the biological testing of the drug. The NIAID award builds on an existing research grant from the National Institute of...

NIH Provides $23 million for Statewide Translational Research Institute

The integrated Translational Health Research Institute of Virginia (iTHRIV) has been awarded a five-year grant of nearly $23 million from the National Institutes of Health (NIH) to advance innovative ideas from the point of discovery to implementation in clinical...

Dr. Umesh Desai, VCU, is Awarded a 5 year Grant

The Desai lab has received the “Glycans in Blood Homeostasis and Disease” grant. This is a five-year K12 grant by National Heart, Lung and Blood Institute to train MDs, PhDs and dual degree holders for advanced careers in glycosciences. Only four such K12 grants were...